2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |

April, 2016

David Casarett’s Stoned: A Doctor’s Case for Medical Marijuana

David Casarett immerses himself in the culture, science, and smoke of medical marijuana in order to sort out the truth behind the buzz. Our reviewer, who has authored more than 120 research papers and reviews on the regulation of synaptic inhibition and endocannabinoids, tell us what the author got right, but also overlooked on his journey to learn more about a complex and controversial subject. 


Read More...

April, 2016

Imaging the Neural Symphony

(Read Q&A with Karel Svoboda, Ph.D.)
Since the start of the new millennium, a method called two-photon microscopy has allowed scientists to peer farther into the brain than ever before. Our article describes the advances that led to this remarkable breakthrough—one that is helping neuroscientists better understand neural networks. Read More...

March, 2016

The Malignant Protein Puzzle

(Read Q&A with Lary C. Walker Ph.D.)
Studying how proteins such as PrP, amyloid beta, tau, and others aggregate and spread, and kill brain cells, represents a crucial new frontier in neuroscience for Alzheimer's, Parkinson's, CTE, and ALS. Read More...

February, 2016

John Seamon’s Memory & Movies: What Films Can Teach Us about Memory

From trauma to amnesia to senior moments, memory has been a major plot line in films since the 1942 classic, Random Harvest. John Seamon, an author and professor of psychology whose research includes how a camera aids memory and the impact of storytelling on memory, has shifted his lens to focus on how memory has been portrayed in one of the world’s most beloved art forms. Read More...

February, 2016

Lithium to the Rescue

(Read Q&A with Richard S. Jope, Ph.D.)
The element lithium is given in capsule form as a mood stabilizer for bipolar disorder and depression. New research, however, reveals its role as a neuroprotector, and suggests that enzymes modulated by lithium could lead to new treatments for Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and other neurodegenerative disorders. Read More...

January, 2016

The Changing Face of Recreational Drug Use

(Read Q&A with Michael H. Baumann, Ph.D.)
Recent data indicate that 540 different drugs classified as new psychoactive substances (NPS) have been identified worldwide as of 2014, and this number is expected to rise. Our article describes the complexity of the NPS problem, what is known about the molecular mechanisms of action, and highlights some of the considerable challenges in dealing with this emerging issue. Read More...

About Cerebrum

 
Bill Glovin, editor
Carolyn Asbury, Ph.D., consultant

Scientific Advisory Board
Joseph T. Coyle, M.D., Harvard Medical School
Kay Redfield Jamison, Ph.D., The Johns Hopkins University School of Medicine
Pierre J. Magistretti, M.D., Ph.D., University of Lausanne Medical School and Hospital
Robert Malenka, M.D., Ph.D., Stanford University School of Medicine
Bruce S. McEwen, Ph.D., The Rockefeller University
Donald Price, M.D., The Johns Hopkins University School of Medicine
Charles Zorumski, M.D., Washington University School of Medicine

Do you have a comment or question about something you've read in CerebrumContact Cerebrum Now.

Cerebrum Anthology 2014

 
Cerebrum2014-80The inspiring ideas and extraordinary challenges facing some of the great minds in brain science make up this sixth annual volume. Expert perspectives into the causes and effects of spatial awareness, empathy, and circadian rhythm appear alongside timely articles and book reviews about cognitive training and brain games; socioeconomic adversity and brain development; and living with autism.
 
Available now at Amazon.